Latest Executive Appointments News

Golden State Mining has appointed Keith Middleton as Managing Director and CEO, bringing over two decades of mining sector expertise and a strategic vision for growth. His leadership comes with a significant share-based incentive, signaling a new chapter for the exploration company.

Lodestar Minerals reports promising gold drilling results at Ned’s Creek, advances exploration in Chile, and announces a strategic acquisition of a US rare earth project.

Gateway Mining has completed its acquisition of the Yandal Gold Project, revealing promising high-grade gold results and securing $22.5 million to fuel extensive exploration and drilling programs.

Ovanti Limited has made significant strides in its U.S. buy now, pay later (BNPL) expansion, securing a major partnership with Shift4 Payments and raising $8 million to fuel growth.

Thunderbird Resources has executed a binding agreement to acquire 100% of the Springfield Gold Deposit in NSW, an advanced project with significant high-grade gold mineralisation. The company also raised $2.2 million to fund exploration and appointed new senior executives to drive growth.

RocketBoots Limited has secured new trial contracts worth $208,000 with major retail banks in Australia and Mexico, while expanding its international sales pipeline and appointing a seasoned CFO/COO to support growth.

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

Percheron Therapeutics reports encouraging phase I clinical results for HMBD-002, confirming safety and early efficacy signals, while gearing up for a multi-arm phase II trial in 2026.

Astral Resources reports robust exploration results across its Western Australian gold projects and key progress on the Mandilla Definitive Feasibility Study, alongside a new joint venture at the Think Big deposit.

Catalina Resources has reported significant gold and rare earth element mineralisation from its Laverton drilling campaigns and secured a 100% interest in the Beasley Creek Gold Project, positioning itself for growth in Western Australia’s mineral sector.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.

Arika Resources has reported exceptional high-grade gold intercepts at its Yundamindra project and expanded its exploration tenure near Kookynie, signalling significant growth potential in Western Australia’s goldfields.